Academic Team

Dr. Kumaravel J

Assistant Professor

Dr. Kumaravel J is an Assistant Professor at SRM CCTR and a Co-Investigator for the ICMR CAR Phase 1 Clinical Trial Network. A PGIMER alumnus and MBBS Gold Medalist, he specializes in early-phase trials, precision medicine, and pharmacovigilance. He has authored 25+ publications and actively mentors MBBS, MD, and PharmD residents.

Biography

Email : kumaravj@srmist.edu.in
Professional registrations/licenses : TNMC 122936 DMC 115678
Trial roles held : Co-Investigator
Areas of trial experience (oncology, cardiology, infectious disease) : Oncology - AML, Antimicrobial stewardship, COVID-19 Master Two-Step Protocol, TDM Levetiracetam in Pregnancy
Total number of trial conducted : 5
Specific trial competencies (informed consent process, AE reporting, monitoring visits, data entry EDC etc) : 1. Informed consent process, 2. AE/SAE reporting
ORCID ID : https://orcid.org/0000-0001-5442-769X

Education

Qualification

Certifications

Professional Experience

Membership in professional bodies

2018 — Present

Incharge, CCTR

SRM MCH & RC
2012 — 2018

Associate Professor

SRM MCH & RC
2010 — 2012

Clinical Research Physician

Multi-centre CRO

Teaching/mentorship roles

Research Interests

Core Research Interest Areas:

Ongoing research projects

Awards

Conference presentations/posters

Paper Presentations

Case Report Presentations

Award-Winning Poster Presentations

Awards and Honors

Publications

Book Chapter

  • Saurabh Sharma, J. Kumaravel, Gurjeet Kaur, Ajay Prakash, Bikash Medhi, Chapter 6 - Target identification for potential drug discovery,
  • Target Identification and Validation. Editor(s): Rupesh Kumar Gautam, Mohammad Amjad Kamal, Pooja Mittal, Computational Approaches in Drug Discovery, Development and Systems Pharmacology, Academic Press, January 2023, Pages 183-196, https://doi.org/10.1016/B978-0-323-99137-7.00008-3.
  • J. Kumaravel, Sowmini K, Ajay Prakash, Bikash Medhi. Ethical, legal and social issues in Therapeutic implications of Pharmacogenomics in clinical scenario 2023

Publications

  • Mahendru D, Kumaravel J, Mahalmani VM, Medhi B. Athlete Biological Passport: Need and Challenges. Indian Journal of Orthopaedics. 2020 Jan 31:1-7.
  • Singh A, Kumaravel J, Mahendru D, Yadav M, Kumar H, Prakash A, Medhi B. Hydroxychloroquine drug safety review for the prophylaxis of SARS COV 2 pandemic. International Journal of Pharmaceutical Sciences and Research. 2020.
  • Kumaravel J, Mahendru D, Mahalmani VM,et al. Athlete Biological Passport: Practical Application in Sports. J Postgrad Med Edu Res 2020
  • Mahalmani V, Kumaravel J, Jain M, Prakash A, Medhi B. Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak. Indian Journal of Pharmacology. 2021 May 1;53(3):187.
  • Kumaravel J, Sowmini K, Avti P, Medhi B. Marathon mice: researcher view on potential roles in preclinical research. Indian Journal of Pharmacology. 2021 Mar 1;53(2):99.
  • Patil AN, Kumar MP, Yadav R, Kosey S, Behl T, Kumaravel J. Drug information services in low-resource settings: a responsibility of pharmacists or pharmacologists or both the professions conjointly. Journal of Pharmacy and Bioallied Sciences. 2021 Apr 1;13(2):283.
  • Mahendru D, Vidya M.Mahalmani, Kumaravel J, Gitika Batra,Prakash A, Medhi B. Recent advances in treatment of myasthenia gravis. Drug Bulletin 2020; 45: 8-15.
  • Kumaravel, Ajay P, Bikash M. Stem Cell Research: Current Update On Efficacy and Safety. Drug Bulletin 2019; 44(1): 1-6.
  • Arjun Singh, Mukesh Yadav, Kumaravel J et al E-Prescription (Cpoe) In Indian Hospitals: A Strategy to Prevent Prescription Errors Drug Bulletin – Volume 45, Issue 3, July 2020
  • Kumaravel J, Medhi B. Management of Poisoning. Dru Bulletin 2022; 47: 1-7
  • Smita P, Narayan PA, J Kumaravel, Gaurav P. Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices. Front Oncol. 2022 Dec 8;12:1015200.
  • Gupta S, Kumaravel J, Prakash A, Medhi B. Concept of essential medicines and recent updates. Indian J Pharmacol. 2023 Jan-Feb;55(1):1-5.
  • Kumaravel J, Singh H, Kaur S, Prakash A, Medhi B. Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19: A brief review. Indian J Pharmacol. 2023 Jan-Feb;55(1):53-58.
  • Choudhary G, Prajapat M, Kumaravel J, Prabha PK, Sarma P, Handa V, Kaur H, Patel AP, Medhi B. Update on omicron variant: What we know so far. Indian J Pharmacol. 2022 Jan-Feb;54(1):41-45.
  • Kumar A, Hegde N, Kumaravel J, Mohindra R, Soni RK, Rathod R, Kumar M, Muthu V, Gamad N, Patil AN, Sharma PL. Comparison of master two-step exercise stress test versus six-min walk test in patients tested positive for SARS-CoV-2. J Family Med Prim Care. 2022 Nov;11(11):7008-7014.
  • Bikash Medhi, J Kumaravel, Prabha PK, Ajay Prakash. Nanomaterials and their Immunological Perspectives. Scopus Indexed [Internet]. 2022 Dec. 12 [cited 2024 May 6];15(6):6191-5.
  • Kumaravel J, Sarma P, Suri V, Singh P, Prakash A, Medhi B. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study. Neurol India. 2024 Mar 1;72(2):358-363.
  • Aditi M Panditrao, Nusrat Shafiq, Suparna Chatterjee, Ashish Pathak, Niyati Trivedi, Balakrishnan Sadasivam et al ASPIRE (‘Antimicrobial Stewardship Programme In Resource-limited Environment’) Study Group - J Kumaravel, A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in India, Journal of Antimicrobial Chemotherapy, Volume 76, Issue 4, April 2021, Pages 1094–1101.
  • Samiksha Bhattacharjee, Chakrant Mothsara, Nusrat Shafiq, Prasan Kumar Panda, Rachna Rohilla,ASPIRE-II (‘Antimicrobial Stewardship Programme In Resource-limited Environment’) Study Group - J Kumaravel et al. Antimicrobial prescription patterns in tertiary care centres in India: a multicentric point prevalence survey, eClinicalMedicine, Volume 82, 2025, 103175, ISSN 2589-5370, https://doi.org/10.1016/j.eclinm.2025.103175. (https://www.sciencedirect.com/science/article/pii/S2589537025001075)
  • Priya Sreenivasan, Rishin Raj, J. Kumaravel, Deepak Kumar, Archana Angrup, Unveiling the uncommon: A rare case report of osteomyelitis caused by Enterococcus avium, Indian Journal of Medical Microbiology, Volume 54, 2025, 100818, ISSN 0255-0857,https://doi.org/10.1016/j.ijmmb.2025.100818. (https://www.sciencedirect.com/science/article/pii/S0255085725000313)
  • Krishnappa N, Kumaravel J, Kumar R, Patil AN. Navigating challenges in paediatric warfarin therapy: a call for standardised guidelines and innovations. Cardiology in the Young. 2025;35(4):876-877. doi:10.1017/S1047951125001180
  • Aditi M Panditrao, Nusrat Shafiq, Suparna Chatterjee, Ashish Pathak, Niyati Trivedi, Balakrishnan Sadasivam et al ASPIRE (‘Antimicrobial Stewardship Programme In Resource-limited Environment’) Study Group - J Kumaravel, A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in India, Journal of Antimicrobial Chemotherapy, Volume 76, Issue 4, April 2021, Pages 1094–1101.
  • Kumaravel J, Divyashanthi, and A.T. Sathiya Vinotha. The Role of Clinical Pharmacologists in Hospital Administration: A Strategic Leadership Perspective. National Board of Examinations - Journal of Medical Sciences Volume 3, Issue 8, Pages 1001–1012, August 2025 DOI 10.61770/NBEJMS.2025.v03.i08.013
  • Kumaravel J , Bikash Medhi. Drugs and Sports: A Perilous Pursuit of Performance Drug Bulletin, PGIMER August 2025
  • Kumar A, Patil AN, Grewal J, Kumaravel J, Shamim MA, Sekar A, Jena A, Singh AK, Kakkar A, Dutta U, Sharma V. Clinical Trial: Long Versus Short Tapering of Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis-A Randomised Controlled Trial. Aliment Pharmacol Ther. 2026 Jan 2. doi: 10.1111/apt.70509. Epub ahead of print. PMID: 41482657
  • Kumaravel J, Divyashanthi CM .Artificial Intelligence in Antimicrobial Stewardship: Is India Ready? JASPI. 2025;3(4)11-13 DOI: 10.62541/jaspi116